Research Article
Knockdown of DIAPH3 Inhibits the Proliferation of Cervical Cancer Cells through Inactivating mTOR Signaling Pathway
Table 3
Expression of DIAPH3 in cervical cancer according to patients’ clinicopathological characteristics.
| Characteristics | Number | DIAPH3 expression | value | High-risk group | Low-risk group |
| Age (years) | <50 | 19 | 11 | 8 | 0.352 | ≥50 | 23 | 10 | 13 |
| Differentiation | Well/moderate | 26 | 12 | 14 | 0.525 | Poor | 16 | 9 | 7 |
| Size (cm) | <3 | 24 | 8 | 16 | 0.013 | ≥3 | 18 | 13 | 5 |
| FIGO stage | I | 24 | 9 | 15 | 0.061 | II and III | 18 | 12 | 6 |
| Lymph node metastasis | No | 25 | 13 | 12 | 0.753 | Yes | 17 | 8 | 9 |
|
|
statistically significant difference. |